Infrastructure
Manufacturing Infrastructure and R&D Capabilities
Pharma Services & Active Ingredients
- Six FDA-approved plants in India
- One FDA-approved plant in Mexico
- One FDA-approved plant in Mirfield, UK
- Four Technology development centers
(Two in Hyderabad, India, One in Cambridge, UK and One in Leiden, Netherlands)
Product Development
- Integrated Product development Capabilities that includes API development, Formulations development and analytical development skills.
- One Integrated Product development facility in Hyderbad, India.
Global Generics
- Seven Formulation plants in India (Two USFDA inspected)
- Two USFDA inspected plant in USA
New Chemical Entities
- Research in the areas of metabolic, cardiovascular, anti-bacterials, and pain & inflammation.
Biologics
- Biologics development center
- GMP production
- E coli and mammalian cell platforms
